PMC:7665480 / 20998-21127
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 451 | 52-62 | Chemical | denotes | everolimus | MESH:D000068338 |
| 454 | 78-86 | Disease | denotes | COVID-19 | MESH:C000657245 |
TEST0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 33084868-125-131-8440 | 125-127 | ["32574238"] | denotes | 27 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T222 | 0-129 | Sentence | denotes | Some authors claim a possible beneficial effect for everolimus as therapy for COVID-19 due to its immunomodulatory activity [27]. |